Citigroup Inc Sc Pharmaceuticals Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Citigroup Inc holds 32,513 shares of SCPH stock, worth $118,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,513
Previous 28,417
14.41%
Holding current value
$118,022
Previous $129,000
10.85%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SCPH
# of Institutions
91Shares Held
38.3MCall Options Held
121KPut Options Held
12.1K-
Orbimed Advisors LLC San Diego, CA6.06MShares$22 Million0.58% of portfolio
-
Rubric Capital Management LP New York, NY4.78MShares$17.3 Million0.28% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.17MShares$15.2 Million5.98% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.86MShares$10.4 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$7.65 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $99.5M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...